ID   TIE2_HUMAN              Reviewed;        1124 AA.
AC   Q02763; A8K6W0; Q5TCU2;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 2.
DT   02-NOV-2010, entry version 126.
DE   RecName: Full=Angiopoietin-1 receptor;
DE            EC=2.7.10.1;
DE   AltName: Full=Tunica interna endothelial cell kinase;
DE   AltName: Full=Tyrosine-protein kinase receptor TEK;
DE   AltName: Full=Tyrosine-protein kinase receptor TIE-2;
DE            Short=hTIE2;
DE   AltName: Full=p140 TEK;
DE   AltName: CD_antigen=CD202b;
DE   Flags: Precursor;
GN   Name=TEK; Synonyms=TIE2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT PRO-346.
RC   TISSUE=Placenta;
RX   MEDLINE=93173509; PubMed=8382358;
RA   Ziegler S.F., Bird T.A., Schneringer J.A., Schooley K.A., Baum P.R.;
RT   "Molecular cloning and characterization of a novel receptor protein
RT   tyrosine kinase from human placenta.";
RL   Oncogene 8:663-670(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PRO-346.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-346.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   PROTEIN SEQUENCE OF 23-37.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [6]
RP   PHOSPHORYLATION, AND DEPHOSPHORYLATION BY PTPRB.
RX   PubMed=19116766; DOI=10.1007/s10456-008-9126-0;
RA   Yacyshyn O.K., Lai P.F.H., Forse K., Teichert-Kuliszewska K.,
RA   Jurasz P., Stewart D.J.;
RT   "Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in
RT   human endothelial cells.";
RL   Angiogenesis 12:25-33(2009).
RN   [7]
RP   INTERACTION WITH PTPRB.
RX   PubMed=19451274; DOI=10.1083/jcb.200811159;
RA   Winderlich M., Keller L., Cagna G., Broermann A., Kamenyeva O.,
RA   Kiefer F., Deutsch U., Nottebaum A.F., Vestweber D.;
RT   "VE-PTP controls blood vessel development by balancing Tie-2
RT   activity.";
RL   J. Cell Biol. 185:657-671(2009).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-596, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [9]
RP   VARIANT VMCM TRP-849.
RX   MEDLINE=97134665; PubMed=8980225; DOI=10.1016/S0092-8674(00)81814-0;
RA   Vikkula M., Boon L.M., Carraway K.L. III, Calvert J.T., Diamonti A.J.,
RA   Goumnerov B., Pasyk K.A., Marchuk D.A., Warman M.L., Cantley L.C.,
RA   Mulliken J.B., Olse B.R.;
RT   "Vascular dysmorphogenesis caused by an activating mutation in the
RT   receptor tyrosine kinase TIE2.";
RL   Cell 87:1181-1190(1996).
RN   [10]
RP   VARIANTS VMCM TRP-849 AND SER-897.
RX   MEDLINE=99299243; PubMed=10369874; DOI=10.1093/hmg/8.7.1279;
RA   Calvert J.T., Riney T.J., Kontos C.D., Cha E.H., Prieto V.G.,
RA   Shea C.R., Berg J.N., Nevin N.C., Simpson S.A., Pasyk K.A.,
RA   Speer M.C., Peters K.G., Marchuk D.A.;
RT   "Allelic and locus heterogeneity in inherited venous malformations.";
RL   Hum. Mol. Genet. 8:1279-1289(1999).
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] ASN-117.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-117; THR-148; VAL-226; ILE-486;
RP   LEU-600; PHE-634; ILE-676; THR-724; ALA-883 AND VAL-1124.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: This protein is a protein tyrosine-kinase transmembrane
CC       receptor for angiopoietin 1. It may constitute the earliest
CC       mammalian endothelial cell lineage marker. Probably regulates
CC       endothelial cell proliferation, differentiation and guides the
CC       proper patterning of endothelial cells during blood vessel
CC       formation.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Interacts with PTPRB.
CC   -!- INTERACTION:
CC       Q05209:PTPN12; NbExp=1; IntAct=EBI-2257090, EBI-2266035;
CC       P23467:PTPRB; NbExp=1; IntAct=EBI-2257090, EBI-1265766;
CC       P08575:PTPRC; NbExp=1; IntAct=EBI-2257090, EBI-1341;
CC       P23470:PTPRG; NbExp=1; IntAct=EBI-2257090, EBI-2258115;
CC       Q12913:PTPRJ; NbExp=1; IntAct=EBI-2257090, EBI-2264500;
CC       Q15262:PTPRK; NbExp=1; IntAct=EBI-2257090, EBI-474052;
CC       Q16827:PTPRO; NbExp=1; IntAct=EBI-2257090, EBI-723739;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in endothelial cells
CC       and their progenitors, the angioblasts. Has been directly found in
CC       placenta and lung, with a lower level in umbilical vein
CC       endothelial cells, brain and kidney.
CC   -!- PTM: Phosphorylated. Phosphorylation is induced by ANGPT1 and
CC       ANGPT2. ANGPT1-induced phosphorylation is impaired during hypoxia.
CC       Dephosphorylated by PTPRB.
CC   -!- DISEASE: Defects in TEK are a cause of dominantly inherited venous
CC       malformations (VMCM) [MIM:600195]; an error of vascular
CC       morphogenesis characterized by dilated, serpiginous channels.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Tie subfamily.
CC   -!- SIMILARITY: Contains 3 EGF-like domains.
CC   -!- SIMILARITY: Contains 3 fibronectin type-III domains.
CC   -!- SIMILARITY: Contains 2 Ig-like C2-type (immunoglobulin-like)
CC       domains.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TEKID42517ch9p21.html";
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/TEK";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L06139; AAA61139.1; -; mRNA.
DR   EMBL; AK291775; BAF84464.1; -; mRNA.
DR   EMBL; AL133411; CAI16055.1; -; Genomic_DNA.
DR   EMBL; AL355432; CAI16055.1; JOINED; Genomic_DNA.
DR   EMBL; AL355433; CAI16055.1; JOINED; Genomic_DNA.
DR   EMBL; CH471071; EAW58571.1; -; Genomic_DNA.
DR   IPI; IPI00412829; -.
DR   PIR; I58388; I58388.
DR   RefSeq; NP_000450.2; -.
DR   UniGene; Hs.89640; -.
DR   PDB; 1FVR; X-ray; 2.20 A; A/B=808-1124.
DR   PDB; 2GY5; X-ray; 2.90 A; A=23-445.
DR   PDB; 2GY7; X-ray; 3.70 A; B=23-445.
DR   PDB; 2OO8; X-ray; 2.20 A; X=808-1124.
DR   PDB; 2OSC; X-ray; 2.80 A; A=808-1124.
DR   PDB; 2P4I; X-ray; 2.50 A; A/B=808-1124.
DR   PDB; 2WQB; X-ray; 2.95 A; A=802-1124.
DR   PDB; 3BEA; X-ray; 2.02 A; A=917-935.
DR   PDBsum; 1FVR; -.
DR   PDBsum; 2GY5; -.
DR   PDBsum; 2GY7; -.
DR   PDBsum; 2OO8; -.
DR   PDBsum; 2OSC; -.
DR   PDBsum; 2P4I; -.
DR   PDBsum; 2WQB; -.
DR   PDBsum; 3BEA; -.
DR   ProteinModelPortal; Q02763; -.
DR   SMR; Q02763; 463-727.
DR   DIP; DIP-6047N; -.
DR   IntAct; Q02763; 20.
DR   STRING; Q02763; -.
DR   PhosphoSite; Q02763; -.
DR   PRIDE; Q02763; -.
DR   Ensembl; ENST00000406359; ENSP00000383977; ENSG00000120156.
DR   GeneID; 7010; -.
DR   KEGG; hsa:7010; -.
DR   CTD; 7010; -.
DR   GeneCards; GC09P027099; -.
DR   HGNC; HGNC:11724; TEK.
DR   HPA; CAB010359; -.
DR   HPA; HPA011738; -.
DR   MIM; 600195; phenotype.
DR   MIM; 600221; gene.
DR   Orphanet; 2451; Mucocutaneous venous malformations.
DR   PharmGKB; PA36441; -.
DR   eggNOG; prNOG04502; -.
DR   HOVERGEN; HBG007316; -.
DR   InParanoid; Q02763; -.
DR   OMA; DAVIYKN; -.
DR   OrthoDB; EOG97Q0RK; -.
DR   PhylomeDB; Q02763; -.
DR   BRENDA; 2.7.10.1; 247.
DR   Pathway_Interaction_DB; angiopoietinreceptor_pathway; Angiopoietin receptor Tie2-mediated signaling.
DR   Reactome; REACT_604; Hemostasis.
DR   ArrayExpress; Q02763; -.
DR   Bgee; Q02763; -.
DR   CleanEx; HS_TEK; -.
DR   Genevestigator; Q02763; -.
DR   GermOnline; ENSG00000120156; Homo sapiens.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0005902; C:microvillus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kin...; TAS:ProtInc.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of protein kinase B sig...; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0051259; P:protein oligomerization; IDA:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:InterPro.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; TAS:ProtInc.
DR   InterPro; IPR006210; EGF-like.
DR   InterPro; IPR013032; EGF-like_reg_CS.
DR   InterPro; IPR000742; EGF_3.
DR   InterPro; IPR008957; Fibronectin_III_dom.
DR   InterPro; IPR003961; FN_III.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR018941; Tyr_kin_Tie2_Ig-like_dom-1_N.
DR   InterPro; IPR015781; Tyr_kinase_angiopoietin_rcpt.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 6.
DR   PANTHER; PTHR23256:SF90; TieRTK; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF00041; fn3; 3.
DR   Pfam; PF10430; Ig_Tie2_1; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00181; EGF; 2.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; FN_III-like; 3.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00022; EGF_1; 3.
DR   PROSITE; PS01186; EGF_2; 3.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   EGF-like domain; Glycoprotein; Immunoglobulin domain; Kinase;
KW   Membrane; Nucleotide-binding; Phosphoprotein; Polymorphism; Receptor;
KW   Repeat; Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL        1     22
FT   CHAIN        23   1124       Angiopoietin-1 receptor.
FT                                /FTId=PRO_0000024474.
FT   TOPO_DOM     23    745       Extracellular (Potential).
FT   TRANSMEM    746    770       Helical; (Potential).
FT   TOPO_DOM    771   1124       Cytoplasmic (Potential).
FT   DOMAIN       44    123       Ig-like C2-type 1.
FT   DOMAIN      210    252       EGF-like 1.
FT   DOMAIN      254    299       EGF-like 2.
FT   DOMAIN      301    341       EGF-like 3.
FT   DOMAIN      350    440       Ig-like C2-type 2.
FT   DOMAIN      445    537       Fibronectin type-III 1.
FT   DOMAIN      544    633       Fibronectin type-III 2.
FT   DOMAIN      639    730       Fibronectin type-III 3.
FT   DOMAIN      824   1096       Protein kinase.
FT   NP_BIND     830    838       ATP (By similarity).
FT   ACT_SITE    964    964       Proton acceptor (By similarity).
FT   BINDING     855    855       ATP (By similarity).
FT   MOD_RES     992    992       Phosphotyrosine; by autocatalysis.
FT   CARBOHYD    140    140       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    158    158       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    399    399       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    438    438       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    464    464       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    560    560       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    596    596       N-linked (GlcNAc...).
FT   CARBOHYD    649    649       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    691    691       N-linked (GlcNAc...) (Potential).
FT   DISULFID    220    233       By similarity.
FT   DISULFID    227    240       By similarity.
FT   DISULFID    242    251       By similarity.
FT   VARIANT     117    117       K -> N (in breast cancer samples;
FT                                infiltrating ductal carcinoma; somatic
FT                                mutation).
FT                                /FTId=VAR_035714.
FT   VARIANT     148    148       I -> T (in dbSNP:rs35969327).
FT                                /FTId=VAR_041855.
FT   VARIANT     226    226       A -> V (in dbSNP:rs35814893).
FT                                /FTId=VAR_041856.
FT   VARIANT     346    346       Q -> P (in dbSNP:rs682632).
FT                                /FTId=VAR_048002.
FT   VARIANT     391    391       T -> I (in dbSNP:rs34032300).
FT                                /FTId=VAR_048003.
FT   VARIANT     486    486       V -> I (in dbSNP:rs1334811).
FT                                /FTId=VAR_024578.
FT   VARIANT     600    600       V -> L (in dbSNP:rs35030851).
FT                                /FTId=VAR_041857.
FT   VARIANT     634    634       L -> F (in dbSNP:rs35378598).
FT                                /FTId=VAR_041858.
FT   VARIANT     676    676       V -> I (in dbSNP:rs56367117).
FT                                /FTId=VAR_041859.
FT   VARIANT     724    724       A -> T (in dbSNP:rs4631561).
FT                                /FTId=VAR_041860.
FT   VARIANT     849    849       R -> W (in VMCM; activating effect).
FT                                /FTId=VAR_006352.
FT   VARIANT     883    883       P -> A (in an ovarian serous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041861.
FT   VARIANT     897    897       Y -> S (in VMCM; activating effect).
FT                                /FTId=VAR_008716.
FT   VARIANT    1124   1124       A -> V (in a renal clear cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041862.
FT   CONFLICT    695    695       T -> I (in Ref. 1; AAA61139).
FT   STRAND       26     29
FT   STRAND       33     35
FT   STRAND       40     46
FT   STRAND       56     59
FT   TURN         61     63
FT   STRAND       64     66
FT   STRAND       74     76
FT   STRAND       80     88
FT   STRAND       98    106
FT   STRAND      109    119
FT   STRAND      123    125
FT   STRAND      127    133
FT   STRAND      139    145
FT   STRAND      153    157
FT   STRAND      160    165
FT   HELIX       167    169
FT   STRAND      172    178
FT   HELIX       183    185
FT   STRAND      187    193
FT   HELIX       198    200
FT   STRAND      202    208
FT   STRAND      215    217
FT   TURN        235    237
FT   STRAND      246    248
FT   STRAND      259    261
FT   TURN        271    276
FT   STRAND      279    281
FT   TURN        282    285
FT   STRAND      286    288
FT   HELIX       296    298
FT   STRAND      322    324
FT   TURN        325    327
FT   STRAND      328    330
FT   STRAND      361    366
FT   STRAND      369    373
FT   HELIX       380    382
FT   STRAND      383    386
FT   STRAND      396    400
FT   STRAND      405    408
FT   STRAND      411    414
FT   HELIX       416    418
FT   STRAND      420    428
FT   STRAND      431    439
FT   STRAND      816    818
FT   HELIX       821    823
FT   STRAND      825    831
FT   HELIX       833    835
FT   STRAND      837    845
FT   STRAND      848    858
FT   HELIX       868    876
FT   STRAND      888    894
FT   STRAND      897    902
FT   HELIX       910    915
FT   HELIX       919    922
FT   HELIX       924    929
FT   HELIX       938    957
FT   HELIX       967    969
FT   STRAND      970    972
FT   HELIX       974    976
FT   STRAND      978    980
FT   STRAND      986    989
FT   TURN       1002   1004
FT   HELIX      1007   1012
FT   HELIX      1017   1032
FT   TURN       1038   1041
FT   HELIX      1044   1050
FT   HELIX      1051   1053
FT   HELIX      1065   1074
FT   HELIX      1079   1081
FT   HELIX      1085   1097
FT   STRAND     1098   1100
FT   HELIX      1118   1120
SQ   SEQUENCE   1124 AA;  125830 MW;  E739DEC3E4FEB124 CRC64;
     MDSLASLVLC GVSLLLSGTV EGAMDLILIN SLPLVSDAET SLTCIASGWR PHEPITIGRD
     FEALMNQHQD PLEVTQDVTR EWAKKVVWKR EKASKINGAY FCEGRVRGEA IRIRTMKMRQ
     QASFLPATLT MTVDKGDNVN ISFKKVLIKE EDAVIYKNGS FIHSVPRHEV PDILEVHLPH
     AQPQDAGVYS ARYIGGNLFT SAFTRLIVRR CEAQKWGPEC NHLCTACMNN GVCHEDTGEC
     ICPPGFMGRT CEKACELHTF GRTCKERCSG QEGCKSYVFC LPDPYGCSCA TGWKGLQCNE
     ACHPGFYGPD CKLRCSCNNG EMCDRFQGCL CSPGWQGLQC EREGIQRMTP KIVDLPDHIE
     VNSGKFNPIC KASGWPLPTN EEMTLVKPDG TVLHPKDFNH TDHFSVAIFT IHRILPPDSG
     VWVCSVNTVA GMVEKPFNIS VKVLPKPLNA PNVIDTGHNF AVINISSEPY FGDGPIKSKK
     LLYKPVNHYE AWQHIQVTNE IVTLNYLEPR TEYELCVQLV RRGEGGEGHP GPVRRFTTAS
     IGLPPPRGLN LLPKSQTTLN LTWQPIFPSS EDDFYVEVER RSVQKSDQQN IKVPGNLTSV
     LLNNLHPREQ YVVRARVNTK AQGEWSEDLT AWTLSDILPP QPENIKISNI THSSAVISWT
     ILDGYSISSI TIRYKVQGKN EDQHVDVKIK NATITQYQLK GLEPETAYQV DIFAENNIGS
     SNPAFSHELV TLPESQAPAD LGGGKMLLIA ILGSAGMTCL TVLLAFLIIL QLKRANVQRR
     MAQAFQNVRE EPAVQFNSGT LALNRKVKNN PDPTIYPVLD WNDIKFQDVI GEGNFGQVLK
     ARIKKDGLRM DAAIKRMKEY ASKDDHRDFA GELEVLCKLG HHPNIINLLG ACEHRGYLYL
     AIEYAPHGNL LDFLRKSRVL ETDPAFAIAN STASTLSSQQ LLHFAADVAR GMDYLSQKQF
     IHRDLAARNI LVGENYVAKI ADFGLSRGQE VYVKKTMGRL PVRWMAIESL NYSVYTTNSD
     VWSYGVLLWE IVSLGGTPYC GMTCAELYEK LPQGYRLEKP LNCDDEVYDL MRQCWREKPY
     ERPSFAQILV SLNRMLEERK TYVNTTLYEK FTYAGIDCSA EEAA
//
